A total of 163 GIST patients were included, of which 153 (93.9%) underwent molecular analysis upfront in our laboratory, while 10 (6.1%) were sent from other laboratories as initially suspected KIT/PDGFRA WT cases. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.